Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
353 studies found for:    leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Condition: Leukemia
Intervention: Drug: Ara-c
2 Recruiting Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALL
Condition: Leukemia
Interventions: Drug: Amsacrine;   Drug: Clofarabine;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin hydrochloride;   Drug: Dexamethasone;   Drug: Doxorubicin hydrochloride;   Drug: Etoposide phosphate;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Thioguanine;   Drug: Vincristine sulfate;   Radiation: Whole-brain radiation therapy
3 Recruiting International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: SR-A + Epratuzumab;   Drug: SR-B + Epratuzumab
4 Recruiting Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HR First Relapse B-precursor ALL
Condition: Leukemia, Acute Lymphoblastic
Interventions: Drug: Blinatumomab;   Drug: Conventional Consolidation Chemotherapy
5 Not yet recruiting International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Condition: Acute Myeloid Leukaemia
Interventions: Drug: Gemtuzumab ozogamicin;   Drug: Liposomal daunorubicin;   Drug: Mitoxantrone;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Busulfan;   Drug: Cyclophosphamide
6 Recruiting Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog
Condition: Adolescents Surviving Childhood Leukemia LEA
Intervention: Other: neuropsychological evaluation
7 Recruiting Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: G-CSF
8 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
9 Recruiting Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.
Condition: Acute Lymphoblastic Leukemia
Intervention: Other: Blood sample
10 Recruiting Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: ITMHA;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Asparaginase Erwinia Chrysanthemi;   Drug: Bortezomib;   Drug: Vorinostat;   Drug: Cyclophosphamide;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Leucovorin Calcium;   Drug: Cytarabine;   Drug: Etoposide;   Drug: Vincristine
11 Recruiting The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: 6-mercaptopurine, Methotrexate;   Drug: 6-mercaptopurine, Methotrexate, Vincristine, Dexamethasone
12 Not yet recruiting A Study to Find a Safe Dose of Volasertib Given in Addition to Standard Salvage Chemotherapy in Children (Age 3 Months to Less Than 18 Years) With Acute Myeloid Leukaemia, in Whom Front-line Chemotherapy Failed
Condition: Leukemia, Myeloid, Acute
Intervention: Drug: Volasertib
13 Recruiting Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA;   Drug: ATRA + IDA
14 Recruiting Epigenetic Reprogramming in Relapse AML
Condition: Leukemia, Acute Myeloid
Interventions: Drug: Decitabine;   Drug: Vorinostat;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim;   Drug: Sorafenib
15 Not yet recruiting Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Cyclophosphamide;   Drug: Physician-Directed Regimens without Cyclophosphamide
16 Recruiting Azacytidine Plus FLAG for Relapsed or Refractory AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Azacytidine;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim
17 Recruiting Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT
Condition: Acute Myeloid Leukemia
Intervention: Drug: Interferon-alpha
18 Recruiting Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine;   Drug: Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
19 Recruiting Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
Condition: Acute Lymphoblastic Leukemia (ALL)
Interventions: Drug: Prednisolone;   Drug: Dexamethasone;   Drug: L-Asparaginase;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Daunorubicin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: 6-Mercaptopurine;   Drug: Thioguanine;   Drug: Fludarabine;   Drug: Imatinib
20 Recruiting Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation
Condition: Leukemia
Intervention: Other: DLI of the 20 fraction of the UCBT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.